Results 221 to 230 of about 547,472 (401)

Association between Smoking and Tumor Progression in Japanese Women with Adenocarcinoma of the Lung [PDF]

open access: green, 1999
Ikuo Sekine   +7 more
openalex   +1 more source

Resident Macrophage‐Orchestrated Immune and Fibroblast Interactions in Immune Checkpoint Inhibitor‐Associated Nephrotoxicity

open access: yesAdvanced Science, EarlyView.
Schematic illustration of resident macrophages in Immune checkpoint inhibitor‐associated nephrotoxicity (ICI‐AN). Using an integrated approach (including imaging mass cytometry, transcriptomics, and murine models), this study reveals that resident macrophages drive immune‐stromal interactions in ICI‐AN, promoting fibroblast activation through CXCL9 and
Yanhong Ma   +11 more
wiley   +1 more source

The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma. [PDF]

open access: bronze, 1996
Yona Kalechman   +6 more
openalex   +1 more source

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

open access: yesCell, 2012
M. Imieliński   +44 more
semanticscholar   +1 more source

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. [PDF]

open access: yesBMC Pulm Med, 2021
Ning J   +8 more
europepmc   +1 more source

Stimuli‐Responsive CuFeTe2 Nanosheets for Amplified Cuproptosis/Ferroptosis in Triple‐Negative Breast Cancer Therapy

open access: yesAdvanced Science, EarlyView.
Dual‐stimuli‐responsive CuFeTe2 nanosheets (CFT) induce cuproptosis/ferroptosis via TME‐responsive Fe2⁺/Cu2⁺ release and NIR‐II photothermal effects, amplifying ROS and depleting HSP70/ATP to trigger ICD and immune activation, while ensuring biocompatible renal clearance for TNBC therapy.
Molin Liu   +14 more
wiley   +1 more source

Postoperative 5-year disease-free rate in patients with small peripheral adenocarcinoma of the lung with respect to histopathological findings.

open access: bronze, 1987
Masahiko Kurata   +11 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy